Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1981 1
1982 1
1983 2
1985 3
1986 2
1987 1
1988 13
1989 12
1990 17
1991 18
1992 14
1993 14
1994 11
1995 6
1996 11
1997 13
1998 17
1999 19
2000 23
2001 29
2002 31
2003 40
2004 47
2005 65
2006 81
2007 86
2008 122
2009 113
2010 138
2011 159
2012 208
2013 242
2014 293
2015 370
2016 403
2017 423
2018 502
2019 578
2020 686
2021 768
2022 880
2023 772
2024 14

Text availability

Article attribute

Article type

Publication date

Search Results

6,492 results

Results by year

Filters applied: . Clear all
Page 1
STING-activating nanoparticles normalize the vascular-immune interface to potentiate cancer immunotherapy.
Wang-Bishop L, Kimmel BR, Ngwa VM, Madden MZ, Baljon JJ, Florian DC, Hanna A, Pastora LE, Sheehy TL, Kwiatkowski AJ, Wehbe M, Wen X, Becker KW, Garland KM, Schulman JA, Shae D, Edwards D, Wolf MM, Delapp R, Christov PP, Beckermann KE, Balko JM, Rathmell WK, Rathmell JC, Chen J, Wilson JT. Wang-Bishop L, et al. Among authors: wen x. Sci Immunol. 2023 May 12;8(83):eadd1153. doi: 10.1126/sciimmunol.add1153. Epub 2023 May 5. Sci Immunol. 2023. PMID: 37146128
Fatty acids in cancer chemoresistance.
Qin J, Ye L, Wen X, Zhang X, Di Y, Chen Z, Wang Z. Qin J, et al. Among authors: wen x. Cancer Lett. 2023 Sep 28;572:216352. doi: 10.1016/j.canlet.2023.216352. Epub 2023 Aug 18. Cancer Lett. 2023. PMID: 37597652 Review.
Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open-label, multicentre, phase 3 trial.
Qin S, Chen M, Cheng AL, Kaseb AO, Kudo M, Lee HC, Yopp AC, Zhou J, Wang L, Wen X, Heo J, Tak WY, Nakamura S, Numata K, Uguen T, Hsiehchen D, Cha E, Hack SP, Lian Q, Ma N, Spahn JH, Wang Y, Wu C, Chow PKH; IMbrave050 investigators. Qin S, et al. Among authors: wen x. Lancet. 2023 Nov 18;402(10415):1835-1847. doi: 10.1016/S0140-6736(23)01796-8. Epub 2023 Oct 20. Lancet. 2023. PMID: 37871608 Clinical Trial.
Photoacoustic remote sensing elastography.
Yuan Y, Wen X, Yuan B, Xin H, Fang B, Yang S, Xiong K. Yuan Y, et al. Among authors: wen x. Opt Lett. 2023 May 1;48(9):2321-2324. doi: 10.1364/OL.485623. Opt Lett. 2023. PMID: 37126264
PT-Symmetric Feedback Induced Linewidth Narrowing.
Tang Y, Liang C, Wen X, Li W, Xu AN, Liu YC. Tang Y, et al. Among authors: wen x. Phys Rev Lett. 2023 May 12;130(19):193602. doi: 10.1103/PhysRevLett.130.193602. Phys Rev Lett. 2023. PMID: 37243661
Efferocytosis: An accomplice of cancer immune escape.
Qiu H, Shao Z, Wen X, Liu Z, Chen Z, Qu D, Ding X, Zhang L. Qiu H, et al. Among authors: wen x. Biomed Pharmacother. 2023 Nov;167:115540. doi: 10.1016/j.biopha.2023.115540. Epub 2023 Sep 21. Biomed Pharmacother. 2023. PMID: 37741255 Free article. Review.
A population-based study on autoimmune disease.
Wen X, Li B. Wen X, et al. Lancet. 2023 Jun 3;401(10391):1829-1831. doi: 10.1016/S0140-6736(23)00621-9. Epub 2023 May 5. Lancet. 2023. PMID: 37156254 No abstract available.
6,492 results